Adage Capital Partners’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-900,000
| Closed | -$3.2M | – | 1172 |
|
|
2022
Q1 | $3.2M | Hold |
900,000
| – | – | 0.01% | 870 |
|
|
2021
Q4 | $4.52M | Hold |
900,000
| – | – | 0.01% | 824 |
|
|
2021
Q3 | $6.59M | Buy |
900,000
+100,000
| +13% | +$732K | 0.01% | 798 |
|
|
2021
Q2 | $6.87M | Buy |
+800,000
| New | +$6.87M | 0.01% | 776 |
|
|
2019
Q4 | – | Sell |
-356,250
| Closed | -$4.9M | – | 776 |
|
|
2019
Q3 | $4.9M | Hold |
356,250
| – | – | 0.01% | 627 |
|
|
2019
Q2 | $5.26M | Buy |
356,250
+106,250
| +43% | +$1.57M | 0.01% | 603 |
|
|
2019
Q1 | $10.5M | Hold |
250,000
| – | – | 0.03% | 519 |
|
|
2018
Q4 | $10.4M | Buy |
250,000
+62,500
| +33% | +$2.6M | 0.03% | 501 |
|
|
2018
Q3 | $9.04M | Buy |
187,500
+162,500
| +650% | +$7.83M | 0.02% | 560 |
|
|
2018
Q2 | $1.19M | Hold |
25,000
| – | – | ﹤0.01% | 705 |
|
|
2018
Q1 | $1.54M | Buy |
+25,000
| New | +$1.54M | ﹤0.01% | 678 |
|